These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 7557094)

  • 21. Genetic polymorphisms of aldehyde dehydrogenase 2, cytochrome p450 2E1 for liver cancer risk in HCV antibody-positive japanese patients and the variations of CYP2E1 mRNA expression levels in the liver due to its polymorphism.
    Kato S; Tajiri T; Matsukura N; Matsuda N; Taniai N; Mamada H; Yoshida H; Kiyam T; Naito Z
    Scand J Gastroenterol; 2003 Aug; 38(8):886-93. PubMed ID: 12940444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of cytochrome P450 2E1 genetic polymorphisms in relation to human lung cancer.
    Kato S; Shields PG; Caporaso NE; Sugimura H; Trivers GE; Tucker MA; Trump BF; Weston A; Harris CC
    Cancer Epidemiol Biomarkers Prev; 1994 Sep; 3(6):515-8. PubMed ID: 8000304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytochrome P450 2E1 and head and neck cancer: interaction with genetic and environmental risk factors.
    Ruwali M; Khan AJ; Shah PP; Singh AP; Pant MC; Parmar D
    Environ Mol Mutagen; 2009 Jul; 50(6):473-82. PubMed ID: 19334053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glutathione S-transferase and cytochrome P450 genotypes as risk factors for laryngeal carcinoma.
    Jahnke V; Strange R; Matthias C; Fryer A
    Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S147-9. PubMed ID: 9065651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers.
    Yu MW; Chiu YH; Yang SY; Santella RM; Chern HD; Liaw YF; Chen CJ
    Br J Cancer; 1999 May; 80(3-4):598-603. PubMed ID: 10408872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of genetic polymorphisms of
    Yang S; Hwang SJ; Park JY; Chung EK; Lee JI
    BMJ Open; 2019 Aug; 9(8):e027940. PubMed ID: 31375612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma.
    Kim JW; Lee CG; Park YG; Kim KS; Kim IK; Sohn YW; Min HK; Lee JM; Namkoong SE
    Cancer; 2000 May; 88(9):2082-91. PubMed ID: 10813720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of CYP2E1 genotype in renal cell and urothelial cancer patients.
    Farker K; Lehmann MH; Oelschlägel B; Haerting J; Hoffmann A; Janitzky V; Schubert J
    Exp Toxicol Pathol; 1998 Sep; 50(4-6):425-31. PubMed ID: 9784018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Genetic polymorphisms of cytochrome P450 2E1 and glutathione S-transferase P1 and susceptibility to esophageal cancer].
    Lin D; Tang Y; Peng Q
    Zhonghua Zhong Liu Za Zhi; 1998 Mar; 20(2):94-7. PubMed ID: 10920953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic polymorphisms of the cancer related gene and Helicobacter pylori infection in Japanese gastric cancer patients. An age and gender matched case-control study.
    Kato S; Onda M; Matsukura N; Tokunaga A; Matsuda N; Yamashita K; Shields PG
    Cancer; 1996 Apr; 77(8 Suppl):1654-61. PubMed ID: 8608558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CYP2E1PstI/RsaI polymorphism and interaction with tobacco, alcohol and GSTs in gastric cancer susceptibility: A meta-analysis of the literature.
    Boccia S; De Lauretis A; Gianfagna F; van Duijn CM; Ricciardi G
    Carcinogenesis; 2007 Jan; 28(1):101-6. PubMed ID: 16837478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo.
    Kato S; Bowman ED; Harrington AM; Blomeke B; Shields PG
    J Natl Cancer Inst; 1995 Jun; 87(12):902-7. PubMed ID: 7666479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers.
    Yu MW; Yang SY; Chiu YH; Chiang YC; Liaw YF; Chen CJ
    Hepatology; 1999 Mar; 29(3):697-702. PubMed ID: 10051470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic polymorphisms of CYP2E1 and GSTM1 in a Thai population.
    Sangrajrang S; Jedpiyawongse A; Srivatanakul P
    Asian Pac J Cancer Prev; 2006; 7(3):415-9. PubMed ID: 17059334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer.
    Suzuki S; Muroishi Y; Nakanishi I; Oda Y
    J Gastroenterol; 2004; 39(3):220-30. PubMed ID: 15064998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytochrome P4502E1 genetic polymorphisms and risk of nasopharyngeal carcinoma: results from a case-control study conducted in Taiwan.
    Hildesheim A; Chen CJ; Caporaso NE; Cheng YJ; Hoover RN; Hsu MM; Levine PH; Chen IH; Chen JY; Yang CS
    Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):607-10. PubMed ID: 8547826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of occupation, lifestyle and genetic polymorphisms of CYP1A1, CYP2E1, GSTM1 and GSTT1 on urinary 1-hydroxypyrene and 2-naphthol concentrations.
    Nan HM; Kim H; Lim HS; Choi JK; Kawamoto T; Kang JW; Lee CH; Kim YD; Kwon EH
    Carcinogenesis; 2001 May; 22(5):787-93. PubMed ID: 11323399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytochrome p450 2E1 polymorphisms and the risk of gastric cardia cancer.
    Cai L; Zheng ZL; Zhang ZF
    World J Gastroenterol; 2005 Mar; 11(12):1867-71. PubMed ID: 15793883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene deletion of glutathione S-transferase M1 and T1 and risk factors of hepatocellular carcinoma in Egyptian patients.
    Abd El-Moneim E; Younis FA; Allam N; Gameel K; Osman M
    Egypt J Immunol; 2008; 15(2):125-34. PubMed ID: 20306695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CYP2E1 genotyping in renal cell/urothelial cancer patients in comparison with control populations.
    Farker K; Lehmann MH; Kästner R; Hoffmann A; Janitzky V; Schubert J; Matz U; Hofmann W
    Int J Clin Pharmacol Ther; 1998 Sep; 36(9):463-8. PubMed ID: 9760005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.